Moderna Inc Says Expects To Absorb The Demand Currently Supported By Lonza At Its Internal Manufacturing Site In Norwood, MA For 2024–2025
Portfolio Pulse from Benzinga Newsdesk
Moderna Inc has announced that it expects to absorb the demand currently supported by Lonza at its internal manufacturing site in Norwood, MA for 2024–2025.
September 19, 2023 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
The news does not directly impact EWL as it is an ETF that tracks the investment results of an index composed of Swiss equities and Lonza is a Swiss company.
EWL is an ETF that tracks the investment results of an index composed of Swiss equities. While Lonza is a Swiss company, the news does not directly impact the ETF as it pertains to Moderna, a US-based company, absorbing Lonza's demand at its Norwood site.
CONFIDENCE 100
IMPORTANCE 0
RELEVANCE 0
POSITIVE IMPACT
Moderna's announcement to absorb Lonza's demand at its Norwood site could potentially increase its production capacity and revenues in 2024-2025.
Moderna's decision to absorb the demand currently supported by Lonza at its Norwood site indicates a potential increase in its production capacity. This could lead to increased revenues in 2024-2025, which would likely have a positive impact on its stock price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100